Bronchial Arterial Chemoembolization Combined with Tislelizumab for Non–Small Cell Lung Cancer: An Exploratory, Prospective, Single-Arm, Phase II Trial

This publication has 29 references indexed in Scilit:

• Clinical outcomes, toxic effect, and immune microenvironment changes of drug-eluting bead bronchial arterial chemoembolisation/bronchial arterial chemoembolization combined with immunotherapy in treating elderly patients with non–small cell lung cancer
  Clinical Radiology, 2025
• Tislelizumab plus chemotherapy as first-line treatment of locally advanced or metastatic nonsquamous non-small-cell lung cancer (final analysis of RATIONALE-304: a randomized phase III trial)
  ESMO Open, 2024
• The Efficacy of Drug-eluting Bead Transarterial Chemoembolization Loaded With Oxaliplatin for the Treatment of Stage III-IV Non-small-cell Lung Cancer
  Academic Radiology, 2022
• Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non–Small-Cell Lung Cancer
  JAMA Oncology, 2021
• The binding of an anti-PD-1 antibody to FcγRΙ has a profound impact on its biological functions
  Cancer Immunology, Immunotherapy, 2018
• An applied anatomical study of bronchial artery
  Surgical and Radiologic Anatomy, 2017
• Transcatheter arterial chemical infusion for advanced non-small-cell lung cancer: long-term outcome and predictor of survival
  La radiologia medica, 2016
• The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
  Journal of Thoracic Oncology, 2016
• FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis
  Cancer Cell, 2015
• The Normal Anatomy and Variations of the Bronchial Arteries: Evaluation with Multidetector Computed Tomography
  Canadian Association of Radiologists Journal, 2015